Literature DB >> 25091416

Diffuse angiopathy in Adams-Oliver syndrome associated with truncating DOCK6 mutations.

Anna Lehman1, Anna-Barbara Stittrich, Gustavo Glusman, Zheyuan Zong, Hong Li, Patrice Eydoux, Christof Senger, Christopher Lyons, Jared C Roach, Millan Patel.   

Abstract

Adams-Oliver syndrome (AOS) is a rare malformation syndrome characterized by the presence of two anomalies: aplasia cutis congenita of the scalp and transverse terminal limb defects. Many affected individuals also have additional malformations, including a variety of intracranial anomalies such as periventricular calcification in keeping with cerebrovascular microbleeds, impaired neuronal migration, epilepsy, and microcephaly. Cardiac malformations can be present, as can vascular dysfunction in the forms of cutis marmorata telangiectasia congenita, pulmonary vein stenoses, and abnormal hepatic microvasculature. Elucidated genetic causes include four genes in different pathways, leading to a model of AOS as a multi-pathway disorder. We identified an infant with mild aplasia cutis congenita and terminal transverse limb defects, developmental delay and a severe, diffuse angiopathy with incomplete microvascularization. Whole-genome sequencing documented two rare truncating variants in DOCK6, a gene associated with a type of autosomal recessive AOS that recurrently features periventricular calcification and impaired neurodevelopment. We highlight an unexpectedly high frequency of likely deleterious mutations in this gene in the general population, relative to the rarity of the disease, and discuss possible explanations for this discrepancy.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Adams-Oliver syndrome; DOCK6; RAC1; angiogenesis; brain malformation; cutis aplasia; pericyte; transverse terminal limb defects; vasculogenesis

Mesh:

Substances:

Year:  2014        PMID: 25091416      PMCID: PMC4167472          DOI: 10.1002/ajmg.a.36685

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  25 in total

1.  Rac1 is required for the formation of three germ layers during gastrulation.

Authors:  K Sugihara; N Nakatsuji; K Nakamura; K Nakao; R Hashimoto; H Otani; H Sakagami; H Kondo; S Nozawa; A Aiba; M Katsuki
Journal:  Oncogene       Date:  1998-12-31       Impact factor: 9.867

2.  Adams-Oliver syndrome with widespread CMTC and fatal pulmonary vascular disease.

Authors:  Ophelia Entsir Dadzie; Lidia Tyszczuk; Susan E Holder; Fernanda Teixeira; Aikaterina Charakida; Julia Scarisbrick; Anthony Chu
Journal:  Pediatr Dermatol       Date:  2007 Nov-Dec       Impact factor: 1.588

3.  Association of Adams-Oliver syndrome and hepatoportal sclerosis: an additional case.

Authors:  Guillaume Pouessel; Anne Dieux-Coeslier; Agnès Wacrenier; Monique Fabre; Frédéric Gottrand
Journal:  Am J Med Genet A       Date:  2006-05-01       Impact factor: 2.802

4.  Dominant modifier DFNM1 suppresses recessive deafness DFNB26.

Authors:  S Riazuddin; C M Castelein; Z M Ahmed; A K Lalwani; M A Mastroianni; S Naz; T N Smith; N A Liburd; T B Friedman; A J Griffith; S Riazuddin; E R Wilcox
Journal:  Nat Genet       Date:  2000-12       Impact factor: 38.330

5.  Dock6, a Dock-C subfamily guanine nucleotide exchanger, has the dual specificity for Rac1 and Cdc42 and regulates neurite outgrowth.

Authors:  Yuki Miyamoto; Junji Yamauchi; Atsushi Sanbe; Akito Tanoue
Journal:  Exp Cell Res       Date:  2006-12-06       Impact factor: 3.905

6.  Scalp and limb defects with cutis marmorata telangiectatica congenita: Adams-Oliver syndrome?

Authors:  H V Toriello; R G Graff; M F Florentine; S Lacina; W D Moore
Journal:  Am J Med Genet       Date:  1988-02

7.  [The Adams-Oliver syndrome in Spain: the epidemiological aspects].

Authors:  M L Martínez-Frías; I Arroyo Carrera; N J Muñoz-Delgado; C Nieto Conde; E Rodríguez-Pinilla; M Urioste Azcorra; F Omeñaca Teres; A García Alix
Journal:  An Esp Pediatr       Date:  1996-07

8.  Autosomal recessive Adams-Oliver syndrome caused by homozygous mutation in EOGT, encoding an EGF domain-specific O-GlcNAc transferase.

Authors:  Idan Cohen; Eldad Silberstein; Yonatan Perez; Daniella Landau; Khalil Elbedour; Yshaia Langer; Rotem Kadir; Michael Volodarsky; Sara Sivan; Ginat Narkis; Ohad S Birk
Journal:  Eur J Hum Genet       Date:  2013-07-17       Impact factor: 4.246

9.  Vascular abnormalities in Adams-Oliver syndrome: cause or effect?

Authors:  E N Swartz; S Sanatani; G G Sandor; R A Schreiber
Journal:  Am J Med Genet       Date:  1999-01-01

10.  Prevalence of known mutations in the familial Mediterranean fever gene (MEFV) in various carrier screening populations.

Authors:  Mario Mikula; Arlene Buller; Weimin Sun; Charles M Strom
Journal:  Genet Med       Date:  2008-05       Impact factor: 8.822

View more
  9 in total

Review 1.  Taking Systems Medicine to Heart.

Authors:  Kalliopi Trachana; Rhishikesh Bargaje; Gustavo Glusman; Nathan D Price; Sui Huang; Leroy E Hood
Journal:  Circ Res       Date:  2018-04-27       Impact factor: 17.367

Review 2.  Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.

Authors:  Mary Ella Pierpont; Martina Brueckner; Wendy K Chung; Vidu Garg; Ronald V Lacro; Amy L McGuire; Seema Mital; James R Priest; William T Pu; Amy Roberts; Stephanie M Ware; Bruce D Gelb; Mark W Russell
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

3.  Rare variants in neuronal excitability genes influence risk for bipolar disorder.

Authors:  Seth A Ament; Szabolcs Szelinger; Gustavo Glusman; Justin Ashworth; Liping Hou; Nirmala Akula; Tatyana Shekhtman; Judith A Badner; Mary E Brunkow; Denise E Mauldin; Anna-Barbara Stittrich; Katherine Rouleau; Sevilla D Detera-Wadleigh; John I Nurnberger; Howard J Edenberg; Elliot S Gershon; Nicholas Schork; Nathan D Price; Richard Gelinas; Leroy Hood; David Craig; Francis J McMahon; John R Kelsoe; Jared C Roach
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-17       Impact factor: 11.205

4.  Mechanism of cell-intrinsic adaptation to Adams-Oliver Syndrome gene DOCK6 disruption highlights ubiquitin-like modifier ISG15 as a regulator of RHO GTPases.

Authors:  Berati Cerikan; Elmar Schiebel
Journal:  Small GTPases       Date:  2017-03-13

5.  CdGAP/ARHGAP31, a Cdc42/Rac1 GTPase regulator, is critical for vascular development and VEGF-mediated angiogenesis.

Authors:  Christine Caron; Jonathan DeGeer; Patrick Fournier; Philippe M Duquette; Vilayphone Luangrath; Hidetaka Ishii; Fereshteh Karimzadeh; Nathalie Lamarche-Vane; Isabelle Royal
Journal:  Sci Rep       Date:  2016-06-07       Impact factor: 4.379

6.  Placental transcriptome co-expression analysis reveals conserved regulatory programs across gestation.

Authors:  Sam Buckberry; Tina Bianco-Miotto; Stephen J Bent; Vicki Clifton; Cheryl Shoubridge; Kartik Shankar; Claire T Roberts
Journal:  BMC Genomics       Date:  2017-01-03       Impact factor: 3.969

7.  Adams Oliver syndrome: A mimicker of familial exudative vitreoretinopathy.

Authors:  Alwaleed M Alsulaiman; Hamad M Alsulaiman; Ahmad Almousa; Sulaiman M Alsulaiman
Journal:  Am J Ophthalmol Case Rep       Date:  2020-04-22

8.  Elucidating the genetic architecture of Adams-Oliver syndrome in a large European cohort.

Authors:  Josephina A N Meester; Maja Sukalo; Kim C Schröder; Denny Schanze; Gareth Baynam; Guntram Borck; Nuria C Bramswig; Duygu Duman; Brigitte Gilbert-Dussardier; Muriel Holder-Espinasse; Peter Itin; Diana S Johnson; Shelagh Joss; Hannele Koillinen; Fiona McKenzie; Jenny Morton; Heike Nelle; Willie Reardon; Claudia Roll; Mustafa A Salih; Ravi Savarirayan; Ingrid Scurr; Miranda Splitt; Elizabeth Thompson; Hannah Titheradge; Colm P Travers; Lionel Van Maldergem; Margo Whiteford; Dagmar Wieczorek; Geert Vandeweyer; Richard Trembath; Lut Van Laer; Bart L Loeys; Martin Zenker; Laura Southgate; Wim Wuyts
Journal:  Hum Mutat       Date:  2018-07-04       Impact factor: 4.878

Review 9.  Congenital diseases caused by defective O-glycosylation of Notch receptors.

Authors:  Yuko Tashima; Tetsuya Okajima
Journal:  Nagoya J Med Sci       Date:  2018-08       Impact factor: 1.131

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.